FDA Brief

Warning letters Drugs

FDA warning letter to

DR Vitamins, LLC dba DR Vitamin Solutions

High riskIssued Sep 11, 2023Posted Sep 12, 2023Center for Drug Evaluation and Research | CDER

FDA warned DR Vitamin Solutions that its eye drops are unapproved new drugs and misbranded.

What happened

In July 2023, FDA reviewed DR Vitamin Solutions’ website, social media pages, and Amazon storefront and found four eye-drop products offered for sale with claims to treat or prevent cataracts and dry eyes. FDA said the products are unapproved new drugs and are not properly listed with FDA. This was a website review, not an inspection.

What FDA found

  1. The eye-drop products are unapproved new drugs because FDA has no approved application for them and they are not generally recognized as safe and effective for their claimed uses.

    FD&C Act §§ 201(p), 505(a), 21 U.S.C. 321(p), 355(a)
  2. The products do not meet FDA’s OTC eye-drug monograph because they contain NAC as an active ingredient and are labeled to treat or prevent cataracts, which the monograph does not allow.

    FD&C Act § 505G, 21 U.S.C. 355h; OTC Monograph M018
  3. The products are misbranded because they are not properly listed with FDA; the Vision Clarity listing has been inactive since January 31, 2020.

    FD&C Act §§ 502(o), 510(j)(1), 21 U.S.C. 352(o), 360(j)(1); 21 CFR 207.41
  4. Website and social-media claims—such as helping cataracts, dry eyes, and floaters—show the products are intended as drugs.

    FD&C Act § 201(g)(1), 21 U.S.C. 321(g)(1)
  5. Selling these products in interstate commerce is prohibited because they are unapproved and misbranded drugs.

    FD&C Act §§ 301(a), 301(d), 21 U.S.C. 331(a), 331(d)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of the steps taken to correct the violations and prevent recurrence, with supporting documents. If the company believes it is not in violation, it must explain why and provide supporting information.

Who should pay attention

  • retailers and online marketplaces selling eye-care products
  • brands marketing NAC eye drops or OTC ophthalmic products
  • quality teams at supplement and OTC drug companies

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk